Session 4: Overall Integrated Viral Clearance and Adventitious Agents Strategy

References

1. 1.↵
   1. Brorson K.,
   2. Levy R.

   Proceedings of the 2011 Viral Clearance Symposium (South San Francisco, CA). PDA J. Pharm. Sci. Technol. 2014, 68 (1), 1.

   OpenUrlFREE Full Text
2. 2.↵
   1. Misegaes G.,
   2. Bailey M.,
   3. Willkommen H.,
   4. Chen Q.,
   5. Roush D.,
   6. Blumel J.,
   7. Brorson K.

   Proceedings of the 2009 Viral Clearance Symposium. Dev. Biol. (Basel) 2010, 133, 69–74.

   OpenUrl
3. 3.↵
   1. Willkommen H.,
   2. Blumel J.,
   3. Brorson K.,
   4. Chen D.,
   5. Chen Q.,
   6. Groner A.,
   7. Kreil T. R.,
   8. Robertson J. S.,
   9. Ruffing M.,
   10. Ruiz S.

   Meeting Report: PDA Virus and TSE Safety Forum. PDA J. Pharm. Sci. Technol. 2013, 67 (2), 81–97.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Willkommen H.,
   2. Blumel J.,
   3. Brorson K.,
   4. Chen D.,
   5. Chen Q.,
   6. Groner A.,
   7. Kreil T. R.,
   8. Robertson J. S.,
   9. Ruffing M.,
   10. Ruiz S.

   Meeting report–workshop on virus removal by filtration: trends and new developments. PDA J. Pharm. Sci. Technol. 2013, 67 (2), 98–104.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Gefroh E.,
   2. Dehghani H.,
   3. McClure M.,
   4. Connell-Crowley L.,
   5. Vedantham G.

   Use of MMV as a single worst-case model virus in viral filter validation studies. PDA J. Pharm. Sci. Technol. 2014, 68 (3), 297–311.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Brorson K.,
   2. Krejci S.,
   3. Lee K.,
   4. Hamilton E.,
   5. Stein K.,
   6. Xu Y.

   Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnol. Bioeng. 2003, 82 (3), 321–329.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Urcan J.

   ASTM E2888-12, Standard Practice for Process for Inactivation of Rodent Retrovirus by pH. ASTM International. 2012. http://www.astm.org/Standards/E2888.htm.
8. 8.↵
   1. Connell-Crowley L.,
   2. Nguyen T.,
   3. Bach J.,
   4. Chinniah S.,
   5. Bashiri H.,
   6. Gillespie R.,
   7. Moscariello J.,
   8. Hinckley P.,
   9. Dehghani H.,
   10. Vunnum S.,
   11. Vedantham G.

   Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes. Biotechnol. Bioeng. 2012, 109 (1), 157–165.

   OpenUrlPubMed
9. 9.↵
   1. Brorson K.,
   2. Brown J.,
   3. Hamilton E.,
   4. Stein E.

   Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use. J. Chromatogr., A 2003, 989 (1), 155–163.

   OpenUrlPubMed
10. 10.↵
    1. Norling L.,
    2. Lute S.,
    3. Emery R.,
    4. Khuu W.,
    5. Voisard M.,
    6. Xu Y.,
    7. Chen Q.,
    8. Blank G.,
    9. Brorson K.

    Impact of multiple re-use of anion exchange chromatography media on virus removal. J. Chromatogr., A 2005, 1069 (1), 79–89.

    OpenUrlPubMed
11. 11.↵
    1. Ma H.,
    2. Galvin T. A.,
    3. Glasner D. R.,
    4. Shaheduzzaman S.,
    5. Khan A.

    Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines. J. Virol. 2014, 88 (12), 6576–6585.

    OpenUrlAbstract/FREE Full Text